Drug Type Small molecule drug |
Synonyms- |
Action agonists |
Mechanism GIPR agonists(Gastric inhibitory polypeptide receptor agonists), GLP-1R agonists(Glucagon-like peptide 1 receptor agonists), PPARα agonists(Peroxisome proliferator-activated receptor α agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Diabetes Mellitus, Type 2 | Preclinical | Germany | 21 Sep 2025 | |
| Diabetes Mellitus, Type 2 | Preclinical | Germany | 21 Sep 2025 | |
| Obesity | Preclinical | Germany | 21 Sep 2025 | |
| Obesity | Preclinical | Germany | 21 Sep 2025 |





